De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Takeda Pharmaceutical Toekomstige groei
Future criteriumcontroles 3/6
Takeda Pharmaceutical zal naar verwachting groeien in winst en omzet met respectievelijk 22.4% en 1.2% per jaar. De winst per aandeel zal naar verwachting groeien met 22.2% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 4.1% zijn.
Belangrijke informatie
22.4%
Groei van de winst
22.2%
Groei van de winst per aandeel
Pharmaceuticals winstgroei | 13.9% |
Inkomstengroei | 1.2% |
Toekomstig rendement op eigen vermogen | 4.1% |
Dekking van analisten | Good |
Laatst bijgewerkt | 23 Sep 2024 |
Recente toekomstige groei-updates
Earnings Beat: Takeda Pharmaceutical Company Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Aug 02Takeda Pharmaceutical Company Limited (TSE:4502) Yearly Results: Here's What Analysts Are Forecasting For This Year
Jun 30Recent updates
Takeda Pharmaceutical (TSE:4502) Is Increasing Its Dividend To ¥98.00
Sep 24Why Investors Shouldn't Be Surprised By Takeda Pharmaceutical Company Limited's (TSE:4502) P/E
Sep 20Takeda Pharmaceutical's (TSE:4502) Upcoming Dividend Will Be Larger Than Last Year's
Aug 08Earnings Beat: Takeda Pharmaceutical Company Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Aug 02Takeda Pharmaceutical (TSE:4502) Is Increasing Its Dividend To ¥98.00
Jul 25Takeda Pharmaceutical's (TSE:4502) Upcoming Dividend Will Be Larger Than Last Year's
Jul 11Takeda Pharmaceutical Company Limited (TSE:4502) Yearly Results: Here's What Analysts Are Forecasting For This Year
Jun 30Takeda Pharmaceutical (TSE:4502) Takes On Some Risk With Its Use Of Debt
Jun 11Some Investors May Be Willing To Look Past Takeda Pharmaceutical's (TSE:4502) Soft Earnings
May 21Takeda Pharmaceutical Company Limited Just Recorded A 6.0% EPS Beat: Here's What Analysts Are Forecasting Next
May 12Takeda Pharmaceutical (TSE:4502) Is Due To Pay A Dividend Of ¥94.00
Mar 28Takeda Pharmaceutical (TSE:4502) Has Announced A Dividend Of ¥94.00
Mar 13Takeda Pharmaceutical (TSE:4502) Will Pay A Dividend Of ¥94.00
Feb 26Winst- en omzetgroeiprognoses
Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
---|---|---|---|---|---|
3/31/2027 | 4,520,755 | 307,430 | 685,725 | 974,901 | 16 |
3/31/2026 | 4,461,741 | 237,525 | 691,722 | 953,200 | 17 |
3/31/2025 | 4,440,578 | 111,937 | 686,602 | 879,592 | 16 |
6/30/2024 | 4,413,134 | 149,920 | 444,957 | 794,248 | N/A |
3/31/2024 | 4,263,762 | 144,067 | 235,614 | 716,344 | N/A |
12/31/2023 | 4,169,049 | 178,219 | -129,035 | 731,449 | N/A |
9/30/2023 | 4,154,414 | 191,626 | 129,243 | 963,227 | N/A |
6/30/2023 | 4,113,631 | 301,398 | 180,765 | 985,315 | N/A |
3/31/2023 | 4,027,478 | 317,017 | 343,467 | 977,156 | N/A |
12/31/2022 | 3,944,611 | 274,525 | 817,615 | 1,059,047 | N/A |
9/30/2022 | 3,749,354 | 213,167 | 789,089 | 1,028,328 | N/A |
6/30/2022 | 3,591,868 | 197,389 | 798,367 | 1,040,488 | N/A |
3/31/2022 | 3,569,006 | 230,059 | 937,068 | 1,123,105 | N/A |
12/31/2021 | 3,465,991 | 438,515 | 902,309 | 1,148,481 | N/A |
9/30/2021 | 3,401,450 | 473,105 | 777,572 | 1,018,931 | N/A |
6/30/2021 | 3,345,565 | 431,178 | 793,645 | 1,031,928 | N/A |
3/31/2021 | 3,197,812 | 376,005 | 774,463 | 1,010,931 | N/A |
12/31/2020 | 3,199,240 | 180,631 | 608,015 | 795,408 | N/A |
9/30/2020 | 3,221,804 | 56,051 | 498,511 | 720,676 | N/A |
6/30/2020 | 3,243,917 | 119,743 | 479,618 | 694,824 | N/A |
3/31/2020 | 3,291,188 | 44,241 | 452,042 | 669,752 | N/A |
12/31/2019 | 3,236,697 | 13,275 | 402,421 | 601,798 | N/A |
9/30/2019 | 2,876,782 | 83,262 | 399,600 | 551,732 | N/A |
6/30/2019 | 2,496,511 | 63,959 | 266,965 | 408,797 | N/A |
3/31/2019 | 2,097,224 | 135,192 | 194,365 | 328,479 | N/A |
12/31/2018 | 1,780,976 | 110,414 | 221,992 | 336,742 | N/A |
9/30/2018 | 1,769,726 | 140,738 | 225,190 | 328,658 | N/A |
6/30/2018 | 1,772,125 | 120,339 | 207,862 | 343,761 | N/A |
3/31/2018 | 1,770,531 | 186,886 | N/A | 377,854 | N/A |
12/31/2017 | 1,785,773 | 190,172 | N/A | 376,566 | N/A |
9/30/2017 | 1,762,667 | 163,457 | N/A | 316,619 | N/A |
6/30/2017 | 1,746,286 | 160,202 | N/A | 285,157 | N/A |
3/31/2017 | 1,732,051 | 114,940 | N/A | 261,363 | N/A |
12/31/2016 | 1,729,967 | 132,194 | N/A | -8,176 | N/A |
9/30/2016 | 1,754,130 | 150,081 | N/A | 42,293 | N/A |
6/30/2016 | 1,795,088 | 155,110 | N/A | 57,618 | N/A |
3/31/2016 | 1,807,378 | 80,166 | N/A | 25,491 | N/A |
12/31/2015 | 1,831,096 | -111,874 | N/A | 203,553 | N/A |
9/30/2015 | 1,830,521 | -152,827 | N/A | 192,836 | N/A |
6/30/2015 | 1,812,971 | -154,591 | N/A | 189,123 | N/A |
3/31/2015 | 1,777,824 | -145,775 | N/A | 182,517 | N/A |
12/31/2014 | 1,744,795 | 75,405 | N/A | N/A | N/A |
9/30/2014 | 1,714,694 | 103,390 | N/A | 240,094 | N/A |
6/30/2014 | 1,692,531 | 110,981 | N/A | N/A | N/A |
3/31/2014 | 1,691,685 | 106,658 | N/A | 148,335 | N/A |
12/31/2013 | 1,655,033 | 103,330 | N/A | N/A | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: De verwachte winstgroei 4502 ( 22.4% per jaar) ligt boven de spaarquote ( 0.3% ).
Winst versus markt: De winst van 4502 ( 22.4% per jaar) zal naar verwachting sneller groeien dan de JP markt ( 8.7% per jaar).
Hoge groeiwinsten: De winst van 4502 zal naar verwachting de komende 3 jaar aanzienlijk groeien.
Omzet versus markt: De omzet van 4502 ( 1.2% per jaar) zal naar verwachting langzamer groeien dan de markt JP ( 4.2% per jaar).
Hoge groei-inkomsten: De omzet van 4502 ( 1.2% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Het rendement op eigen vermogen 4502 zal naar verwachting over 3 jaar laag zijn ( 4.1 %).